Insulin-like growth factor 1 stimulation of androgen receptor activity requires β 1A integrins

Journal of Cellular Physiology

Volumn 227, Issue 2, 2012, Pages 751-758

  Sayeed, Aejaz ^a   Alam, Naved ^b   Trerotola, Marco ^a   Languino, Lucia R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Premas Biotechnology Pvt Limited   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BETA1A INTEGRIN; GLYCOPROTEIN; METRIBOLONE; PROTEIN KINASE B; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEEDBACK SYSTEM; HORMONAL REGULATION; HUMAN; HUMAN CELL; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ANDROGENS; ANIMALS; ANTIGENS, CD29; CELL LINE, TUMOR; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; RECEPTOR, IGF TYPE 1; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION;

EID: 82155181710     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22784     Document Type: Article

References (44)

1. Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, Sawyer TK, Languino LR. 2007. The integrin-growth factor receptor duet. J Cell Physiol 213: 649-653.
2. Aleksic T, Chitnis MM, Perestenko OV, Gao S, Thomas PH, Turner GD, Protheroe AS, Howarth M, Macaulay VM. 2010. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Res 70: 6412-6419.
3. Baserga R. 2009. Customizing the targeting of IGF-1 receptor. Future Oncol 5: 43-50.
4. Boudreau N, Bissell MJ. 1998. Extracellular matrix signaling: Integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10: 640-646.
5. Craft N, Shostak Y, Carey M, Sawyers CL. 1999. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nat Med 5: 280-285.
6. Culig Z. 2004. Androgen receptor cross-talk with cell signalling pathways. Growth Factors 22: 179-184.
7. Culig Z, Bartsch G. 2006. Androgen axis in prostate cancer. J Cell Biochem 99: 373-381.
8. Culig Z, Bartsch G, Hobisch A. 2002. Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol Cell Endocrinol 197: 231-238.
9. Dai J, Shen R, Sumitomo M, Stahl R, Navarro D, Gershengorn MC, Nanus DM. 2002. Synergistic activation of the androgen receptor by bombesin and low-dose androgen. Clin Cancer Res 8: 2399-2405.
10. Desai SJ, Ma AH, Tepper CG, Chen HW, Kung HJ. 2006. Inappropriate activation of the androgen receptor by nonsteroids: Involvement of the Src kinase pathway and its therapeutic implications. Cancer Res 66: 10449-10459.
11. Fang Y, Fliss AE, Robins DM, Caplan AJ. 1996. Hsp90 regulates androgen receptor hormone binding affinity in vivo. J Biol Chem 271: 28697-28702.
12. Fornaro M, Manes T, Languino LR. 2001. Integrins and prostate cancer metastases. Cancer Metastasis Rev 20: 321-331.
13. 1C integrin in prostatic adenocarcinoma. J Clin Invest 103: 321-329.
14. Foster BA, Gingrich JR, Kwon ED, Madias C, Greenberg NM. 1997. Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. Cancer Res 57: 3325-3330.
15. Genua M, Pandini G, Sisci D, Castoria G, Maggiolini M, Vigneri R, Belfiore A. 2009. Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells. Cancer Res 69: 7270-7277.
16. Girnita L, Girnita A, Larsson O. 2003. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci USA 100: 8247-8252.
17. 1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts. Cancer Res 65: 6692-6700.
18. 1 integrins. J Cell Biol 166: 407-418.
19. Goel HL, Li J, Kogan S, Languino LR. 2008. Integrins in prostate cancer progression. Endocr Relat Cancer 3: 657-664.
20. Jemal A, Siegel R, Xu J, Ward E. 2010. Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
21. Knudsen KE, Penning TM. 2010. Partners in crime: Deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol Metab 21: 315-324.
22. Kyprianou N, Isaacs JT., 1988. Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 123: 2124-2131.
23. Lin HK, Yeh S, Kang HY, Chang C. 2001. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc Natl Acad Sci USA 98: 7200-7205.
24. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP. 2001. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276: 13442-13451.
25. Malinowska K, Neuwirt H, Cavarretta IT, Bektic J, Steiner H, Dietrich H, Moser PL, Fuchs D, Hobisch A, Culig Z. 2009. Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Endocr Relat Cancer 16: 155-169.
26. Manning BD, Cantley LC. 2007. AKT/PKB signaling: Navigating downstream. Cell 129: 1261-1274.
27. Metalli D, Lovat F, Tripodi F, Genua M, Xu SQ, Spinelli M, Alberghina L, Vanoni M, Baffa R, Gomella LG, Iozzo RV, Morrione A. 2010. The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin. Am J Pathol 176: 2997-3006.
28. Monami G, Emiliozzi V, Morrione A. 2008. Grb10/Nedd4-mediated multiubiquitination of the insulin-like growth factor receptor regulates receptor internalization. J Cell Physiol 216: 426-437.
29. Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C. 2003. Modulation of androgen receptor transactivation by gelsolin: A newly identified androgen receptor coregulator. Cancer Res 63: 4888-4894.
30. Pandini G, Mineo R, Frasca F, Roberts CT, Jr., Marcelli M, Vigneri R, Belfiore A. 2005. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Cancer Res 65: 1849-1857.
31. 1 integrin variants in human prostate carcinoma. Am J Pathol 157: 1727-1734.
32. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R. 1999. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19: 7203-7215.
33. Plymate SR, Tennant MK, Culp SH, Woodke L, Marcelli M, Colman I, Nelson PS, Carroll JM, Roberts CT, Jr., Ware JL. 2004. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Prostate 61: 276-290.
34. Prins GS, Putz O. 2008. Molecular signaling pathways that regulate prostate gland development. Differentiation 76: 641-659.
35. Rahman MM, Miyamoto H, Lardy H, Chang C. 2003. Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells. Proc Natl Acad Sci USA 100: 5124-5129.
36. Reddy GP, Barrack ER, Dou QP, Menon M, Pelley R, Sarkar FH, Sheng S. 2006. Regulatory processes affecting androgen receptor expression, stability, and function: Potential targets to treat hormone-refractory prostate cancer. J Cell Biochem 98: 1408-1423.
37. Sehat B, Tofigh A, Lin Y, Trocme E, Liljedahl U, Lagergren J, Larsson O. 2010. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal 3: ra10.
38. Singh RR, Kumar R. 2005. Steroid hormone receptor signaling in tumorigenesis. J Cell Biochem 96: 490-505.
39. Taplin ME, Balk SP. 2004. Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 91: 483-490.
40. Ting HJ, Yeh S, Nishimura K, Chang C. 2002. Supervillin associates with androgen receptor and modulates its transcriptional activity. Proc Natl Acad Sci USA 99: 661-666.
41. Vecchione A, Marchese A, Henry P, Rotin D, Morrione A. 2003. The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol 23: 3363-3372.
42. Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH, Hung MC. 2000. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res 60: 6841-6845.
43. Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR. 2006. Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem 99: 392-401.
44. Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, Chang C. 1999. From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proc Natl Acad Sci USA 96: 5458-5463.